Status:
ACTIVE_NOT_RECRUITING
Added Value of Preoperative Contrast Enhanced Mammography in Staging of Malignant Breast Lesions
Lead Sponsor:
Region Halland
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Patients diagnosed with breast cancer after routine assessment with digital mammography and ultrasound and scheduled for primary surgery are included in the trial. The patients are randomized 1:1 to g...
Eligibility Criteria
Inclusion
- Planned primary surgery for suspicious or verified breast malignancy Age of 18 years and above Signed informed consent
Exclusion
- Planned neoadjuvant therapy On-going pregnancy Iodinated contrast agent allergy Renal failure (abnormal S-creatinine) Untreated thyreotoxicosis Severe heart failure Myastenia gravis Breast implant Local recurrence as index lesion Inability to understand and comprehend oral and written information of the study
Key Trial Info
Start Date :
November 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2029
Estimated Enrollment :
441 Patients enrolled
Trial Details
Trial ID
NCT04437602
Start Date
November 2 2020
End Date
December 31 2029
Last Update
May 7 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Halland Hospital Halmstad
Halmstad, Sweden, 301 85
2
Helsingborg Hospital
Helsingborg, Sweden, 252 23
3
Central Hospital Kristianstad
Kristianstad, Sweden, 291 33